Rising Chronic Disorders Prevalence Driving Growth In The Induced Pluripotent Stem Cell Market: The Driving Engine Behind Induced Pluripotent Stem Cell (iPSC) Market Evolution in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Induced Pluripotent Stem Cell (iPSC) Market Size Growth Forecast: What to Expect by 2025?
The market encompassing induced pluripotent stem cells (iPSCs) has seen swift expansion lately; projections indicate its value maturing from $3.3 billion in 2024 to reach $3.67 billion by 2025, reflecting an 11.3% compound annual growth rate. This upward trajectory over the historical period is fueled by several factors, including escalating healare spending, greater financial investment flowing into the sector, heightened general knowledge concerning the therapeutic capabilities of stem cell-derived products, the application of iPSC technology in discovering new pharmaceuticals, the mounting requirement for treatments tailored to individuals, and the economical advantages that iPSC research offers for drug development processes.

How Will the Induced Pluripotent Stem Cell (iPSC) Market Size Evolve and Grow by 2029?
Anticipation is for substantial expansion within the induced pluripotent stem cell (ipsc) market throughout the impending years, projecting a valuation of $5.29 billion by 2029, driven by a compound annual growth rate (CAGR) stabilizing at 9.6%. This upward trajectory is fueled by several factors, notably the rising incidence of long-term illnesses, advancements in genomic undertakings, the creation of disease modeling systems utilizing IPSCs, a greater occurrence of hereditary conditions, supportive governmental programs, and swift technological progress. Key shifts anticipated during this projection timeframe encompass the creation of pluripotent stem cells specifically targeting Parkinson's disease (PD), the formation of tactical alliances and cooperative agreements, the engineering of NK cells derived from induced pluripotent stem cells (IPSC), the application of IPSC for cellular therapies, increased funding dedicated to regenerative medicine research and development efforts, the creation of specialized IPSC expansion media, the tailoring of personalized IPSCs, and the advancement of pluripotent stem cells designed to address type I diabetes.

View the full report here:
https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

What Drivers Are Propelling the Growth of Induced Pluripotent Stem Cell (iPSC) Market Forward?
The expanding incidence of long-term ailments stands as a primary catalyst propelling the expansion within the induced pluripotent stem cell market, given that conditions like cardiac ailments, malignancies, cerebrovascular accidents, and diabetes are amenable to treatment utilizing these cells. Induced pluripotent stem cells, which originate from various tissues harvested from either children or adults, undergo genetic alteration to exhibit functional characteristics akin to embryonic stem cells. Data from a Partnership to Fight Chronic Disorder (PFCD) publication indicated that nearly half of the American populace, specifically 45 percent of 133 million individuals, live with a minimum of one chronic condition. Furthermore, estimates suggest that chronic disorders account for seven out of every ten fatalities in the United States, totaling around 1.7 million deaths annually, a mortality rate that could potentially be mitigated through the application of induced pluripotent stem cell therapies, thus fueling the market's growth trajectory due to the escalating frequency of these persistent health issues.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

Which Emerging Trends Are Transforming the Induced Pluripotent Stem Cell (iPSC) Market in 2025?
Firms operating within the Induced Pluripotent stem cell sector are actively seeking avenues for forming strategic alliances and cooperative ventures, aiming to facilitate market penetration into novel territories and broaden their range of offerings; this trend is exemplified by the agreement struck in January 2022 where Bristol Myers Squibb and Century Therapeutics initiated a strategic collaboration focused on engineering IPSC-derived allogeneic cell treatments targeted against acute myeloid leukemia and multiple myeloma, which was further mirrored in May 2022 when Evotec and Sernova established a strategic partnership to advance the creation of an IPSC-centered beta cell replacement therapy designed for managing both type 1 and type 2 diabetes.

What Are the Key Segments in the Induced Pluripotent Stem Cell (iPSC) Market?
The induced pluripotent stem cell (ipsc)market covered in this report is segmented -

1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types
2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy
3) By End-User: Hospitals, Research Laboratories

Subsegments:
1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing; Disease Modeling And Regenerative Therapies
2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair; Fibroblast-Based Disease Research
3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research; Skin Regeneration Therapies
4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research; Amniotic Fluid-Based Regenerative Applications
5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling; Cardiomyocytes For Heart Disease Studies; Endothelial Cells For Vascular Research

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2515&type=smp

Who Are the Key Players Shaping the Induced Pluripotent Stem Cell (iPSC) Market's Competitive Landscape?
Major companies operating in the induced pluripotent stem cell (iPSC) market include FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio, Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, Takaria Bio, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, MSD, Pfizer, Roche, Pharmasyntez, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, GlaxoSmithKline, Parexel, Bayer, Fate Therapeutics, Athersys, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, VistaGen Therapeutics, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

What Geographic Markets Are Powering Growth in the Induced Pluripotent Stem Cell (iPSC) Market?
North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2024. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (IPSC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2515

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.